Second-line treatment for advanced non-small cell lung cancer: how to design a clinical trial for a new agent?

Lung Cancer. 2007 Feb;55(2):135-6. doi: 10.1016/j.lungcan.2006.10.005. Epub 2006 Nov 21.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Clinical Trials as Topic*
  • Disease Progression
  • Docetaxel
  • Glutamates / therapeutic use*
  • Guanine / analogs & derivatives*
  • Guanine / therapeutic use
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Pemetrexed
  • Research Design*
  • Survival Rate
  • Taxoids / therapeutic use*

Substances

  • Antineoplastic Agents
  • Glutamates
  • Taxoids
  • Pemetrexed
  • Docetaxel
  • Guanine